UA6823U - Method for treating acute experimental pancreatitis - Google Patents
Method for treating acute experimental pancreatitisInfo
- Publication number
- UA6823U UA6823U UA20041209835U UA20041209835U UA6823U UA 6823 U UA6823 U UA 6823U UA 20041209835 U UA20041209835 U UA 20041209835U UA 20041209835 U UA20041209835 U UA 20041209835U UA 6823 U UA6823 U UA 6823U
- Authority
- UA
- Ukraine
- Prior art keywords
- treating acute
- acute experimental
- experimental pancreatitis
- pancreatitis
- treating
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The method for treating the acute experimental pancreatitis provides for intravenous administration of the liposomal form of Dalargin and intrabursal administration of Deltaran.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA20041209835U UA6823U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UA20041209835U UA6823U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
UA6823U true UA6823U (en) | 2005-05-16 |
Family
ID=34883911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20041209835U UA6823U (en) | 2004-12-01 | 2004-12-01 | Method for treating acute experimental pancreatitis |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA6823U (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
EP3622964A1 (en) | 2018-09-12 | 2020-03-18 | PVP Labs PTE. Ltd. | Agent for the treatment of skin wounds or burns |
-
2004
- 2004-12-01 UA UA20041209835U patent/UA6823U/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
EP3556377A1 (en) | 2018-04-18 | 2019-10-23 | PVP Labs PTE. Ltd. | Antiviral immunotropic agent for the treatment of acute respiratory viral infections |
EP3622964A1 (en) | 2018-09-12 | 2020-03-18 | PVP Labs PTE. Ltd. | Agent for the treatment of skin wounds or burns |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
MX349188B (en) | Sns-595 and methods of using the same. | |
PL377443A1 (en) | Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis | |
ZA200407813B (en) | Medicament for preventing and/or treating chronic rejection. | |
WO2005048942A3 (en) | Combination therapy comprising a cox-2 inhibitor and an antineoplastic agent | |
WO2006060507A3 (en) | Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders | |
AU2002236527A1 (en) | Nutrient supplements and methods for treating autism and for preventing the onset of autism | |
WO2005000213A3 (en) | Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors | |
WO2006055871A3 (en) | Treatment for multiple sclerosis | |
WO2005044093A3 (en) | Delta-9- the treatment of multiple sclerosis | |
PL359056A1 (en) | Compound emulsion, method of manufacture of the compound emulsion and application of the compound emulsion | |
NZ571858A (en) | Methods of treating, reducing and inhibiting the appearance of ageing in the skin | |
EP1642592A4 (en) | Remedy for sarcoidosis and method of treating the same | |
WO2008034116A3 (en) | Products and methods using soy peptides to lower total and ldl cholesterol levels | |
TW200507840A (en) | Method of treating multiple myeloma | |
WO2002094189A3 (en) | Compositions and methods for treating or preventing convulsions or seizures | |
PT1596868E (en) | Method for treating severe heart failure and medicament therefor | |
UA88655C2 (en) | S-mirtazapine for the treatment of hot flush | |
WO2001052855A3 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone | |
WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
MY122838A (en) | Treating allergic and inflammatory conditions | |
UA6823U (en) | Method for treating acute experimental pancreatitis | |
AU2003252527A1 (en) | Fatty emulsion injection of seal oil, method for preparation and the use in manufacturing intravenous injection | |
TW200637604A (en) | Cosmetic compositions containing sophora alopecuroides L. extracts | |
WO2004080477A8 (en) | Aplidine for multiple myeloma treatment |